Antidiabetic activity of extracts of Anacardium occidentale Linn. leaves on n-streptozotocin diabetic rats

Journal of Traditional and Complementary Medicine

Volumn 7, Issue 4, 2017, Pages 421-427

  Jaiswal, Y S ^a   Tatke, P A ^a   Gabhe, S Y ^a   Vaidya, A B ^b  

^a SNDT WOMEN S UNIVERSITY   (India)

^b Genetic Research Centre India   (India)

Author keywords

Anacardium occidentale; Leaves; Neonatal induced diabetic rats; Streptozotocin; Type 2 diabetes

Indexed keywords

EID: 85009355054     PISSN: None     EISSN: 22254110     Source Type: Journal    
DOI: 10.1016/j.jtcme.2016.11.007     Document Type: Article

References (37)

1. Word Health Organization, web page: http://www.who.org, 2006 (accessed February, 2012).
2. Inzucchi, S., Classification and diagnosis of diabetes mellitus. Porte, D., Sherwin, R., Baron, A., (eds.) Elenberg and Rifkin's Diabetes Mellitus, 2003, McGraw Hill, New York.
3. Paris, R., Plat, M., Giono-Barder, P., Linhard, J., et Laurens, A., Recherche chimique et pharmacologique sur les feuilles d'Anacardium occidentale L. (Anacardiace'es). Bull la Société deMédecine d'Afrique Noire Lang Française 22 (1977), 275–281.
4. Felcman, J., Braganca, M.L., Chromium in plants: comparison between the concentration of chromium in Brasilian nonhypo and hypoglycemic plants. Biol Trace Elem Res 17 (1987), 11–16.
5. Gupta, M., Arias, T., Correa, M., Lamba, S., Ethnopharmacognostic observations on Panamanian medicinal plants. Part I Q J Crude Drug Res 17 (1979), 115–130.
6. Goncalves, J., Lopes, R., Oliveira, D., et al. In vitro anti-rotavirus activity of some medicinal plants used in Brazil against diarrhea. J Ethnopharmacol 99 (2005), 403–407.
7. Schmourloa, G., Ricardo, R., Mendonca, F., Celuta, S., Sonia, S., Screening of antifungal agents using ethanol precipitation and bioautography of medicinal and food plants. J Ethnopharmacol 96 (2005), 563–568.
8. Wedson, S., Mourãob, J., Raynner, B., Alvesb, R., Parallels between zootherapeutic practices in ethnoveterinary and human complementary medicine in northeastern Brazil. J Ethnopharmacol 134 (2011), 753–767.
9. Iwu, M.M., Handbook of African Medicinal Plants. 1993, CRC Press, Boca Raton, FL.
10. Oliver-Bever, B., Medicinal Plants in Tropical West Africa. 1986, Cambridge University Press, London.
11. Coe, F.G., Anderson, G.J., Ethnobotany of the Garifuna of Eastern Nicaragua. Econ Bot 50 (1996), 71–108.
12. Gill, L., Akinwumi, C., Nigerian folk medicine: practices and beliefs of the Ondo people. J Ethnopharmacol 18 (1986), 259–266.
13. Barrett, B., Medicinal plants of Nicaragua's Atlantic coast. Econ Bot 48 (1994), 8–20.
14. Konan, N., Bacchi, E., Lincopan, N., Varela, S., Varanda, E., Acute, subacute toxicity and genotoxic effect of a hydroethanolic extract of the cashew (Anacardium occidentale L.). J Ethnopharmacol 110 (2007), 30–38.
15. Carvalhoa, A., Annonia, R., Silva, P., et al. Acute, subacute toxicity and mutagenic effects of anacardic acids from cashew (Anacardium occidentale Linn.) in mice. J Ethnopharmacol 135 (2011), 730–736.
16. Kamtchouing, P., Selestin, D., Sokeng, P., Moundipa, P., Hermine, B., Lontsi, D., Protective role of Anacardium occidentale extract against streptozotocin-induced diabetes in rats. J Ethnopharmacol 62 (1998), 95–99.
17. Arya, R., Babu, V., Ilyas, M., Nasim, K.T., Phytochemical examination of the leaves of Anacardium occidentale. J Indian Chem Soc 66 (1989), 67–68.
18. Laurens, A., Paris, R.R., Sur les polyphe'nols d'Anacardiacées Africaines et Malgaches: Poupartia birrea Aub., Poupartia caffra H. Perr. et Anacardium occidentale L. Plantes Médicinales Phytothérapie 11 (1977), 16–24.
19. Swarnalakshni, T., Gomathi, K., Sulschana, N., Baskar, E.A., Parmar, N.S., Anti-inflammatory activity of (-) epicatechin, a biflavonoid isolated from Anacardium occidentale Linn. Indian J Pharm Sci 43 (1981), 205–208.
20. Verspohl, E.J., Recommended testing in diabetes research. Planta Medica 68 (2000), 581–590.
21. OECD/OCDE 423, OECD Guideline for Testing of Chemicals, Acute Oral Toxicity – Acute Toxic Class Method, Environment Directorate Organisation For Economic Co-Operation And Development, Paris, (Adopted: 17th December 2001).
22. Ogbonnia, S.O., Mbaka, G.O., Igbokwe, N.H., Anyika, E.N., Nwakakwu, N., Antimicrobial evaluation, acute and subchronic toxicity studies of Leone Bitters, a Nigerian polyherbal formulation in rodents. Agric Biol J N Am 1 (2010), 366–376.
23. Saha, P., Mazumber, U.K., Halder, P.K., Islam, A., Kumar, S.R.B., Evaluation of acute and subchronic toxicity of Lagenaria siceraria aerial part. Int J Pharm Sci Res 2 (2011), 1507–1512.
24. Nandy, S., Datta, R., Acute and subacute toxicity studies of methanolic leaves extract of Pterospermum acerifolium L. wild in rodents. Int J Pharm Life Sci 3 (2012), 1519–1529.
25. Kulkarni, C.P., Bodhankar, S.L., Ghule, A.K., Mohan, V., Thakurdesai, P.A., Antidiabetic activity of trigonella foenumgraecum l. Seeds extract (ind01) in neonatal streptozotocin-induced (n-stz) rats. Diabetol Croat 41 (2012), 29–40.
26. Patil, M.A., Suryanarayana, P., Putcha, U.K., Srinivas, M., Reddy, G.B., Evaluation of neonatal streptozotocin induced diabetic rat model for the development of cataract. Oxid Med Cell Longev, 2014, 463264.
27. Inoguchi, T., Li, P., Umeda, F., et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49 (2000), 1939–1945.
28. Rahimi, R., Nikfar, S., Larijani, B., Abdollahi, M., A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 59 (2005), 365–373.
29. Poretsky, L., Principles of Diabetes Mellitus. 2010, Springer, Boston, MA, USA.
30. Palm, F., Ortsater, H., Hansell, P., Liss, P., Carlsson, P.O., Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model. Diabetes Metab Res Rev 20 (2004), 452–459.
31. Rauter, A.P., Martins, A., Borges, C., et al. Antihyperglycaemic and protective effects of flavonoids on streptozotocin-induced diabetic rats. Phytother Res 24:suppl 2 (2010), S133–S138.
32. Qinna, N.A., Badwan, A.A., Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats. Drug Des Dev Ther 9 (2015), 2515–2525, 10.2147/DDDT.S79885.
33. Zhou, J.Y., Zhou, S.W., Zhang, K.B., et al. Chronic effects of berberine on blood, liver glycolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. Biol Pharm Bull 31 (2008), 1169–1176.
34. Lane, T.A., Lamkin, G.E., Wancewicz, E.V., Protein kinase C inhibitors block the enhanced expression intercellular adhesion molecule-1 on endothelial cells activated by interleukin-1, lipopolysaccharide and tumor necrosis factor. Biochem Biophys Res Commun 172 (1990), 1273–1281.
35. Leegwater, D.C., Kuper, C.F., Evaluation of histological changes in the kidneys of the alloxan diabetic rat by means of factor analysis. Food Chem Toxicol 22 (1984), 551–557.
36. Rodrigo, R., Bosso, C., Oxidative stress and protective effects of polyphenols: comparative studies in human and rodent kidney. A review. Comp Biochem Physiol C 142 (2006), 317–327.
37. Srinivasan, K., Ramarao, P., Animal models in type 2 diabetes research: an overview. Indian J Med Res 125 (2007), 451–472.